Literature DB >> 7819936

Population based survival rates for childhood cancer in Britain, 1980-91.

C A Stiller1.   

Abstract

OBJECTIVES: To investigate the survival of children with cancer diagnosed during 1980-91 in order to assess the impact of developments in medical care on a population basis.
DESIGN: Retrospective cohort study.
SETTING: Great Britain.
SUBJECTS: 14973 children with cancer diagnosed during 1980-91 and included in the population based National Registry of Childhood Tumours. MAIN OUTCOME MEASURES: Actuarial survival rates.
RESULTS: For all cancers combined, two year survival increased from 66% to 76% between 1980-2 and 1989-91, and five year survival increased from 57% to 65% between 1980-2 and 1986-8. Significant increases in survival rates occurred among children with acute lymphoblastic leukaemia, acute nonlymphocytic leukaemia, retinoblastoma, osteosarcoma, Ewing's sarcoma, rhabdomyosarcoma, and malignant gonadal germ cell tumours. No trend in survival was seen for children with Hodgkin's disease, central nervous system tumours, neuroblastoma, or Wilms's tumour.
CONCLUSIONS: Nearly two thirds of children who have cancer diagnosed can now expect to survive at least 10 years.

Entities:  

Mesh:

Year:  1994        PMID: 7819936      PMCID: PMC2541972          DOI: 10.1136/bmj.309.6969.1612

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  28 in total

1.  Overtreatment of children with Wilms' tumour outside paediatric oncology centres.

Authors:  J Pritchard; C A Stiller; E L Lennox
Journal:  BMJ       Date:  1989-09-30

2.  Very-high-dose cisplatin and etoposide in children with untreated advanced neuroblastoma.

Authors:  O Hartmann; C R Pinkerton; T Philip; J M Zucker; F Breatnach
Journal:  J Clin Oncol       Date:  1988-01       Impact factor: 44.544

3.  Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.

Authors:  J R Mann; D Pearson; A Barrett; F Raafat; J M Barnes; K R Wallendszus
Journal:  Cancer       Date:  1989-05-01       Impact factor: 6.860

4.  Centralisation of treatment and survival rates for cancer.

Authors:  C A Stiller
Journal:  Arch Dis Child       Date:  1988-01       Impact factor: 3.791

5.  Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.

Authors:  C A Stiller; G J Draper
Journal:  Arch Dis Child       Date:  1989-05       Impact factor: 3.791

6.  Ifosfamide in previously untreated disseminated neuroblastoma. Results of Study 3A of the European Neuroblastoma Study Group.

Authors:  S J Kellie; J De Kraker; J S Lilleyman; A Bowman; J Pritchard
Journal:  Eur J Cancer Clin Oncol       Date:  1988-05

7.  Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival.

Authors:  B M Sanders; G J Draper; J E Kingston
Journal:  Br J Ophthalmol       Date:  1988-08       Impact factor: 4.638

8.  Improvement in prognosis of neuroblastoma through mass population screening.

Authors:  H Naito; M Sasaki; K Yamashiro; T Takeda; N Takasugi; J Uchino; Y Hata
Journal:  J Pediatr Surg       Date:  1990-02       Impact factor: 2.545

9.  Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503.

Authors:  O B Eden; I Hann; J Imeson; S Cotterill; M Gerrard; C R Pinkerton
Journal:  Br J Haematol       Date:  1992-10       Impact factor: 6.998

10.  Incidence of second primary tumours among childhood cancer survivors.

Authors:  M M Hawkins; G J Draper; J E Kingston
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

View more
  32 in total

1.  Childhood cancer survival in Cuba.

Authors:  M G Boschmonar; Y G Alvarez; A M García; T N Soto; M C Roger; L F Garrote
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

Review 2.  Clinical management of brain stem glioma.

Authors:  D A Walker; J A Punt; M Sokal
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

Review 3.  Chemotherapy for retinoblastoma: a current topic.

Authors:  P T Finger; G Czechonska; H Demirci; A Rausen
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

4.  Spatial clustering of childhood cancers in Great Britain.

Authors:  E G Knox; E A Gilman
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

5.  Follow-up care for young adult survivors of cancer: lessons from pediatrics.

Authors:  Christine Eiser; Kate Absolom; Diana Greenfield; John Snowden; Robert Coleman; Barry Hancock; Helena Davies
Journal:  J Cancer Surviv       Date:  2007-03       Impact factor: 4.442

6.  Subcutaneous autologous testicle transplantation in Wistar rats.

Authors:  Antônio Miragem; Brasil Silva Neto; Mateus Reche; Lúcia M Kliemann; Edison Capp; Helena von Eye Corleta
Journal:  Int Urol Nephrol       Date:  2008-09-18       Impact factor: 2.370

7.  Human Fertility and Embryology Act 1990 discriminates against children. Children must not be denied future choice of using their gametes.

Authors:  M Hewitt; D Walker; M Sokal
Journal:  BMJ       Date:  1998-04-04

8.  Corticosteroids in the management of central nervous system tumours. Kids Neuro-Oncology Workshop (KNOWS).

Authors:  A W Glaser; N Buxton; D Walker
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

Review 9.  Retinoblastoma: an overview.

Authors:  Anish Ray; Dan S Gombos; Tribhawan S Vats
Journal:  Indian J Pediatr       Date:  2012-03-16       Impact factor: 1.967

10.  Descriptive epidemiology of childhood cancers in Bangalore, India.

Authors:  A Nandakumar; N Anantha; L Appaji; K Swamy; G Mukherjee; T Venugopal; S Reddy; M Dhar
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.